NAFLD导致选择性CD4 ((+) T淋巴细胞损失,并促进肝癌发生
Chi Ma1, Aparna H Kesarwala2, Tobias Eggert1
1Gastrointestinal Malignancy Section, Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
非酒精性脂肪肝 (NAFLD) 通过降低CD4T细胞,加速肝癌的抗瘤免疫力. 通过反应性氧物种 (ROS) 阻断恢复这些细胞可以延缓肝细胞癌 (HCC) 的生长.
科学领域:
- 免疫学
- 肝病学
- 代谢疾病研究
背景情况:
- 肝细胞癌 (HCC) 是癌症死亡的主要原因.
- 非酒精性脂肪肝 (NAFLD) 是一个日益严重的公共卫生问题,也是HCC的风险因素.
- 与NAFLD相关的HCC背后的免疫机制尚不清楚.
研究的目的:
- 研究适应性免疫在NAFLD促进的HCC中的作用.
- 确定受NAFLD影响的特定免疫细胞群.
- 在这种情况下阐明驱动免疫失调的分子机制.
主要方法:
- 分析小鼠模型和人类肝脏样本.
- 流细胞测量以评估淋巴细胞数量.
- 线粒体测定和反应性氧物种 (ROS) 生产的评估.
- 在体内的实验涉及ROS阻塞.
主要成果:
- 导致肝脏内CD4 ((+) T细胞的选择性耗尽,而不是CD8 ((+) T细胞.
- 与CD4 ((+) T细胞相比,它们的线粒体质量和ROS产量更高.
- 在NAFLD中积累的酸会加剧线粒体功能障碍和CD4 ((+) T细胞损失.
- 在体内阻断ROS恢复了CD4 ((+) T细胞数量和减弱了HCC的进展.
结论:
- 在NAFLD中,脂质代谢失调通过选择性CD4 ((+) T细胞损失损害了抗瘤免疫监测.
- 线粒体功能障碍和ROS在这个过程中起着至关重要的作用.
- 针对ROS可能为NAFLD相关的HCC提供治疗策略.
更多相关视频
09:27Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
Published on: April 1, 2021
08:20Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model
Published on: December 2, 2022
相关概念视频
Hepatitis
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
